Becton, Dickinson and Company’s BDX, or popularly known as BD, initiated the recall of its infusion pumps last month after customer reports indicated software issues, potentially leading to inaccurate...
Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)
Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks
/Becton%20Dickinson%20%26%20Co_%20logo%20on%20phone-by%20T_Schneider%20via%20Shutterstock.jpg)
Becton, Dickinson and Company has lagged behind the broader healthcare sector recently, yet Wall Street analysts remain highly optimistic about its future growth potential.
BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group
Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)
Solventum (SOLV) Reports Q4: Everything You Need To Know Ahead Of Earnings
Boston Scientific Corporation BSX, despite industrywide macroeconomic upheavals, has been seeing strong growth momentum across its target markets. Earlier this month, the company posted robust fourth-quarter...
Investors in Becton Dickinson and Company BDX, popularly known as BD, need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $120.00 Put...
/Becton%20Dickinson%20%26%20Co_%20office%20building-by%20JHVEPhoto%20via%20Shutterstock.jpg)
MedTech giant Becton, Dickinson and Company underperformed relative to the broader market over the past year, but Wall Street analysts remain upbeat about the stock’s potential.
In 2024, Abbott Laboratories ABT faced industry-wide challenges that exerted pressure on its profit margins. Factors such as rising inflation, labor shortages and supply chain disruptions resulted in increased...
Becton Dickinson: Fiscal Q1 Earnings Snapshot
BD (BDX) To Report Earnings Tomorrow: Here Is What To Expect
Hologic HOLX is set to release first-quarter fiscal 2025 results on Feb. 5 after the closing bell.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.The Zacks Consensus Estimate...
Medtronic MDT has started the year 2025 on a positive note, with the stock climbing nearly 7% so far in January. This surge in market optimism follows the CMS' recent move to initiate a national coverage...
Shares of Hologic HOLX recorded a new 52-week low of $69.46 during Monday’s trading before finishing slightly higher at $70.29. Yesterday, the stock ended at $70.20, marking the lowest close in recent...
/CNW/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the results of a new survey revealing that 74%...
MedTech giant Becton, Dickinson and Company is expected to unveil its first-quarter results in the upcoming month and analysts expect a notable double-digit growth in earnings.
These three highly-rated companies offer a combination of growth and at least 25 years of increasing dividends.
/Baxter%20International%20Inc_%20logo%20on%20building-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Baxter International has lagged behind its peers in the medical devices industry over the past three months, and analysts are cautious about the stock's prospects.
These three highly-rated dividend growth stocks are trading cheap. Find out if now is the time to buy.
Discover 3 top income stocks with low payout ratios, strong buy ratings, and long-term growth potential.
Becton, Dickinson and Company have underperformed the Dow Jones Industrials Average over the past year, yet Wall Street analysts maintain a bullish outlook on the stock’s prospects.
Roland Goette, the EVP and President of $BDX ($BDX), sold 638 shares of the company on 12-09-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.3% of their...
Roland Goette, the EVP and President of $BDX ($BDX), sold 4,483 shares of the company on 12-06-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 15.6% of their...
David Shan, the EVP and Chief ISC Officer of $BDX ($BDX), sold 1,500 shares of the company on 12-05-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 19.3%...
/Becton%20Dickinson%20%26%20Co_%20BACTEC%20by-%20TheBlueHydrangea%20via%20Shutterstock.jpg)
Despite Becton, Dickinson and Company’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.
On Monday, Hologic HOLX released its fiscal 2024 fourth-quarter financial report after the closing bell, with revenues slightly surpassing the consensus mark. The bottom line fell short of estimates...
Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.81 in the fourth quarter of fiscal 2024, up 11.4% year over year. The figure topped the Zacks...